<div class="headers"><div>Figure 6 Percentage of patients with ≥30%, ≥50%, ≥70%, and ≥90% improvement on the WOMAC pain subscale at week 16 in the subgroups.  Notes: *P≤0.05; **P≤0.01; ***P≤0.001 vs placebo. ^P≤0.05; ^^P≤0.01; ^^^P≤0.001 vs naproxen.  Abbreviations: BID, twice daily; OA, osteoarthritis; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; border-bottom: 2px solid grey; text-align: left;'><p class="">Figure 6 Percentage of patients with ≥30%, ≥50%, ≥70%, and ≥90% improvement on the WOMAC pain subscale at week 16 in the subgroups.  Notes: *P≤0.05; **P≤0.01; ***P≤0.001 vs placebo. ^P≤0.05; ^^P≤0.01; ^^^P≤0.001 vs naproxen.  Abbreviations: BID, twice daily; OA, osteoarthritis; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.</p></td>
</tr>
</tbody>
</table>
